*Five Years Citation in Google scholar (2016 - 2020) is. 1451*   *    IJPR IS INDEXED IN ELSEVIER EMBASE & EBSCO *       

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence
Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Treatment Features of Viral Hepatitis B and C in The Russian Federation

Author: ARTUR ALMUKHAMETOV, ILIA VLADIMIROVICH PETROV, FIRUZA SALAVATOVNA PETROVA, ALFIR NEBIULLOVICH KHISAMUTDINOV
Abstract: The treatment of infectious because of hepatitis B and C remain an urgent problem for modern healthcare. This study allowed us establishing some of the trends associated with the above infectious pathologies in the Russian Federation for 2013-2017. There is a decrease in the incidence of acute viral hepatitis B among the general population by 1.54 times and acute viral hepatitis C by 1.2 times. A 2-fold decrease in the incidence of acute hepatitis B among children and adolescents of 0–17 years old has been established, and an acute hepatitis C disease has decreased in 1.6 times over the study period in the above-mentioned cohort. Vaccination of the population against viral hepatitis B over the years analyzed remains at a stable level both among the general population (2013 - 4.1 million people; 2017 - 3.27 million people) and in the cohort of 0-17 years old (2013 - 1.7 million people; 2017 - 1.77 million people). The work carried out established that the carrier rate of the hepatitis B among the entire population decreased by 1.2 times for 2013–2017 (2013 - 11.69 per 100 thousand of the population; 2017 - 9.6 per 100 thousand of the population). The incidence of chronic viral hepatitis B decreased 1.6 times for the analyzed period (2013 - 16.24 per 100 thousand of the population; 2017 - 10.13 per 100 thousand of the population), and chronic viral hepatitis C - 1.13 times (2013 - 39.21 per 100 thousand of the population; 2017 - 34.6 per 100 thousand of the population).
Keyword: viral hepatitis B and C, markers, epidemiology, infectious diseases.
DOI: https://doi.org/10.31838/ijpr/2020.12.01.153
Download: Request For Article
 




ONLINE SUBMISSION
USER LOGIN
Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free